The head of the Food and Drug Administration faced congressional lawmakers Thursday amid the baby formula shortage that has ricocheted across the country.
Robert Califf said Abbott Laboratories and the FDA is on track to open their Sturgis, Michigan, baby formula plant during a congressional hearing.Facing tough scrutiny from both Democrats and Republicans, FDA Commissioner Robert Califf ton Thursday told lawmakers the agency has made"significant progress" in working to reopen the closed Abbott baby formula plant that triggered the nationwide shortage, but conceded it will be weeks before the supply gets back to normal.
But even when Abbot, the nation's largest infant formula manufacturer, does restart operations at its Sturgis, Michigan, facility, it will still take time to ramp up production -- six to eight weeks before the product is back on shelves. Califf's appearance came just hours after President Joe Biden announced new steps to ramp up the federal response to the crisis, a problem that had been brewing for months.o help expedite domestic manufacturing and allow military aircraft to fly formula into the U.S. from overseas.The Abbott manufacturing facility in Sturgis, Mich., May 13, 2022.
"It makes me question which side the FDA is on," DeLauro said."Are they on the side of Abbott, and industry, or on the side of the American consumer, in this case babies and their moms and dads?""We know many parents and caregivers are feeling frustrated," Califf said.
This crisis now"exemplifies the problem that we face when we have a concentrated industry where taking out one plant has such an enormous impact. This creates a situation where we have a delicate balance. If conditions are unsafe, how do we get the plant back up and operating without interrupting the supply?" Califf said."We had to really wrestle this to the ground with Abbott.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Lawmakers grill FDA commissioner over baby formula shortageThe Food and Drug Administration's commissioner is facing congressional lawmakers for the first time over the national shortage of baby formula
Lire la suite »
Amid infant formula fallout, FDA turns to agency veteran with little food experienceFood groups are calling Janet Woodcock's new assignment a “slap in the face.”
Lire la suite »
FDA authorizes new over-the-counter COVID-19 testUnlike any other, it uses a nasal swab sample to test for COVID, flu and respiratory syncytial virus at the same time.
Lire la suite »
Massie slams FDA and USDA, blames them for baby formula and meat shortagesRep. Thomas Massie blamed the FDA and USDA for baby formula and meat shortages, saying they contribute to the high prices and lack of supply.
Lire la suite »
FDA authorizes Pfizer COVID-19 booster for kids 5-11A rise in new COVID-19 cases among children was reported overnight by health leaders but there may be extra protection coming for those children in the form of booster doses of vaccines. Andrea Nakano reports. (5-17-22)
Lire la suite »
Zealand Pharma to seek FDA approval of its treatment for rare genetic disorder in babiesU.S.-listed shares of Zealand Pharma undefinedundefined soared 21.2% in premarket trading on Thursday after the company said a Phase 3 clinical trial...
Lire la suite »